IPS is an Oxford based HealthTech company specializing in identifying and engaging global HCPs and patients from the Rare Diseases sector, gathering insights and knowledge that enable our clients to develop clinical and commercial strategies, and build unique and long-term digital relationships.

IPS’s renowned team of researchers, international scientists, medics, compliance and technical experts manage all aspects of our research, including contracting and compliance, providing our clients with an end-to-end solution.